Articles

Analysis from the CPhI Annual Report has revealed that the global contract services sector is benefitting from a switch toward COVID-19 manufacturing and clinical-stage contracts; however, mega-cap pharma innovation is slowing outsourcing.

CPhI Annual Report Reveals that COVID-19 is Benefitting CDMOs 

Vifor Pharma and Angion Biomedica have signed a license agreement that will see the commercialization of late-stage product, ANG-3777.

Vifor Pharma, Angion Sign License Agreement for Commercialization of ANG-3777

Optibrium has entered into a cheminformatics collaboration with MSD (known as Merck & Co. in the United States).

Optibrium, MSD Enter Cheminformatics Collaboration

Construction on the workshop is currently underway with plans for it to be fully operational by the end of 2021.

Novasep to Invest $7.6 million to Expand API Manufacturing Workshop Capacity

Agnes Shanley is senior editor of Pharmaceutical Technology.

Clarity from regulators, prior work on other vaccines, and closer collaboration with contract partners and suppliers have allowed Moderna and J&J to slash timeframes. Moderna may be on track to deliver initial doses to the highest risk patient populations before January 2021.

The Last Mile: COVID-19 Vaccine Developers Prepare to File for Emergency Use Authorizations

The program will consist of 10 University of Cambridge researchers and a group of PhD students who will work together to develop AI and machine learning technologies for clinical trials, personalized medicine, and biomedical discovery.

The University of Cambridge, AstraZeneca, and GlaxoSmithKline to Fund Cambridge Centre for AI in Medicine

The companies will initially develop and design process technologies, single-use systems, and automation, with plans to eventually focus on an expanding process and digital technologies to optimize a continuous manufacturing process. 

Merck Announces Collaboration with Transcenta for Continuous Manufacturing for Protein Therapeutics

ISPE announced its 2020–2021 International Board of Directors during the virtual 2020 ISPE Annual Meeting & Expo on Nov. 6, 2020. 

ISPE Announces 2020–2021 International Board of Directors

FDA issued emergency use authorization for bamlanivimab for patients at risk for severe COVID-19.

Lilly’s COVID-19 mAb Treatment Receives EUA

The agreement provides Novo Nordisk with full access to Emisphere’s Eligen SNAC technology, which will boost Novo Nordisk’s portfolio of oral therapeutics. 

News